☰

Scott Powers - Publications

Affiliations: 
Applied Mathematics and Statistics Stony Brook University, Stony Brook, NY, United States 
Area:
Statistics
Tree Info Similar researchers PubMed Report error

71 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Rao M, Nemajerova A, Li J, Gao M, Oh K, Moffit R, Kim J, Georgakis G, Sasson A, Bialkowkska A, Powers S. Abstract A42: Single-cell RNA-seq analysis of human pancreatic ductal adenocarcinoma identifies a novel cell type expressing the intestinal stem cell marker OLFM4 Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-A42  0.315
2018 Rao M, Powers S. Tandem Duplications May Supply the Missing Genetic Alterations in Many Triple-Negative Breast and Gynecological Cancers. Cancer Cell. 34: 179-180. PMID 30107171 DOI: 10.1016/J.Ccell.2018.07.011  0.319
2017 Choi M, Bien H, Mofunanya A, Powers S. Challenges in Ras therapeutics in pancreatic cancer. Seminars in Cancer Biology. PMID 29170065 DOI: 10.1016/J.Semcancer.2017.11.015  0.375
2017 Zhao X, Powers S. New Views into the Genetic Landscape of Metastatic Breast Cancer. Cancer Cell. 32: 131-133. PMID 28810140 DOI: 10.1016/J.Ccell.2017.07.011  0.326
2017 Chen M, Nowak DG, Narula N, Robinson B, Watrud K, Ambrico A, Herzka TM, Zeeman ME, Minderer M, Zheng W, Ebbesen SH, Plafker KS, Stahlhut C, Wang VM, Wills L, ... ... Powers S, et al. The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. The Journal of Cell Biology. PMID 28193700 DOI: 10.1083/Jcb.201604025  0.369
2016 Lee HJ, Li CF, Ruan D, Powers S, Thompson PA, Frohman MA, Chan CH. The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation. Molecular Cell. PMID 27618486 DOI: 10.1016/J.Molcel.2016.08.009  0.369
2016 Scott KL, Powers S. Functionally Assessing Candidate Drivers Advances Precision Cancer Medicine. Cancer Cell. 30: 187-189. PMID 27505666 DOI: 10.1016/J.Ccell.2016.07.011  0.35
2016 Powers S, Pollack RE. Inducing stable reversion to achieve cancer control. Nature Reviews. Cancer. 16: 266-70. PMID 27458638 DOI: 10.1038/Nrc.2016.12  0.324
2016 Li J, Sordella R, Powers S. Effectors and potential targets selectively upregulated in human KRAS-mutant lung adenocarcinomas. Scientific Reports. 6: 27891. PMID 27301828 DOI: 10.1038/Srep27891  0.367
2016 Escobar-Hoyos L, Vanner EA, Schechter S, Roa-Pena L, Li J, Wint J, Powers S, Akalin A, Bandovic J, Bailey P, Chang DK, Moffit RA, Yeh JJ, Biankin A, Shroyer KR. Abstract B76: Translating keratin 17 status to stratify clinically relevant pancreatic cancer heterogeneity and survival Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-B76  0.307
2016 Wu S, Powers S, Zhu W, Hannun Y. Abstract 2589: Dissecting extrinsic and intrinsic cancer risk Cancer Research. 76: 2589-2589. DOI: 10.1158/1538-7445.Am2016-2589  0.313
2015 Bott AJ, Peng IC, Fan Y, Faubert B, Zhao L, Li J, Neidler S, Sun Y, Jaber N, Krokowski D, Lu W, Pan JA, Powers S, Rabinowitz J, Hatzoglou M, et al. Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation. Cell Metabolism. PMID 26603296 DOI: 10.1016/J.Cmet.2015.09.025  0.32
2015 Powers S. Cooperation between MYC and companion 8q genes in hepatocarcinogenesis. Hepatology (Baltimore, Md.). 61: 757-8. PMID 25418077 DOI: 10.1002/Hep.27605  0.308
2014 Rudalska R, Dauch D, Longerich T, McJunkin K, Wuestefeld T, Kang TW, Hohmeyer A, Pesic M, Leibold J, von Thun A, Schirmacher P, Zuber J, Weiss KH, Powers S, Malek NP, et al. In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer. Nature Medicine. 20: 1138-46. PMID 25216638 DOI: 10.1038/Nm.3679  0.303
2014 Catanzaro J, Sheshadri N, Pan J, Sun Y, Shi C, Li J, Powers S, Crawford H, Zong W. Abstract A23: Oncogenic Ras induces inflammatory cytokine production by upregulating squamous cell carcinoma antigen (SerpinB3) Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-A23  0.35
2013 Cleary SP, Jeck WR, Zhao X, Chen K, Selitsky SR, Savich GL, Tan TX, Wu MC, Getz G, Lawrence MS, Parker JS, Li J, Powers S, Kim H, Fischer S, et al. Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology (Baltimore, Md.). 58: 1693-702. PMID 23728943 DOI: 10.1002/Hep.26540  0.322
2013 Cleary SP, Jeck WR, Zhao X, Selitsky SR, Savich GL, Tan T, Wu MC, Getz G, Lawrence MS, Parker JS, Li J, Powers S, Kim H, Fischer SE, Guindi M, et al. Abstract 4598: Identification of driver genes in hepatocellular carcinoma by exome sequencing. Cancer Research. 73: 4598-4598. DOI: 10.1158/1538-7445.Am2013-4598  0.339
2012 Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, Revill K, Weissmueller S, Rappaport AR, Simon J, Zhang J, Luo W, Hicks J, Zender L, Wang XW, ... Powers S, et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proceedings of the National Academy of Sciences of the United States of America. 109: 8212-7. PMID 22566646 DOI: 10.1073/Pnas.1206062109  0.39
2012 Rajaram M, Powers S, Egeblad M, Li J. Abstract LB-500: Genomic and RNAi analyses identify diverse oncogenic interactions between breast cancer cells and stromal fibroblasts Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-500  0.573
2011 Liu-Sullivan N, Zhang J, Bakleh A, Marchica J, Li J, Siolas D, Laquerre S, Degenhardt YY, Wooster R, Chang K, Hannon GJ, Powers S. Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1) Oncotarget. 2: 1254-1264. PMID 22248814 DOI: 10.18632/Oncotarget.406  0.322
2011 Storm P, Aits S, Puthia MK, Urbano A, Northen T, Powers S, Bowen B, Chao Y, Reindl W, Lee DY, Sullivan NL, Zhang J, Trulsson M, Yang H, Watson JD, et al. Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis. Oncogene. 30: 4765-79. PMID 21643007 DOI: 10.1038/Onc.2011.196  0.37
2011 Sawey ET, Chanrion M, Cai C, Wu G, Zhang J, Zender L, Zhao A, Busuttil RW, Yee H, Stein L, French DM, Finn RS, Lowe SW, Powers S. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell. 19: 347-58. PMID 21397858 DOI: 10.1016/J.Ccr.2011.01.040  0.32
2011 Revill K, Tim W, GInther CL, Anderson L, Aleshin A, Busuttil RW, Powers S, Finn RS. Abstract 3937: Global methylation patterns, genome copy number alterations and expression analysis distinguish two distinct subclasses of hepatocellular carcinoma Cancer Research. 71: 3937-3937. DOI: 10.1158/1538-7445.Am2011-3937  0.351
2010 Schreiber SL, Shamji AF, Clemons PA, Hon C, Koehler AN, Munoz B, Palmer M, Stern AM, Wagner BK, Powers S, Lowe SW, Guo X, Krasnitz A, Sawey ET, et al. Towards patient-based cancer therapeutics. Nature Biotechnology. 28: 904-6. PMID 20829823 DOI: 10.1038/Nbt0910-904  0.355
2010 Trotman L, Powers S. New views into the prostate cancer genome. Cancer Cell. 18: 1-2. PMID 20609345 DOI: 10.1016/J.Ccr.2010.06.011  0.311
2010 Degenhardt Y, Greshock J, Laquerre S, Gilmartin AG, Jing J, Richter M, Zhang X, Bleam M, Halsey W, Hughes A, Moy C, Liu-Sullivan N, Powers S, Bachman K, Jackson J, et al. Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability. Molecular Cancer Therapeutics. 9: 2079-89. PMID 20571075 DOI: 10.1158/1535-7163.Mct-10-0095  0.341
2010 Oliver TG, Mercer KL, Sayles LC, Burke JR, Mendus D, Lovejoy KS, Cheng MH, Subramanian A, Mu D, Powers S, Crowley D, Bronson RT, Whittaker CA, Bhutkar A, Lippard SJ, et al. Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes & Development. 24: 837-52. PMID 20395368 DOI: 10.1101/Gad.1897010  0.342
2009 Bric A, Miething C, Bialucha CU, Scuoppo C, Zender L, Krasnitz A, Xuan Z, Zuber J, Wigler M, Hicks J, McCombie RW, Hemann MT, Hannon GJ, Powers S, Lowe SW. Functional identification of tumor-suppressor genes through an in vivo RNA interference screen in a mouse lymphoma model. Cancer Cell. 16: 324-35. PMID 19800577 DOI: 10.1016/J.Ccr.2009.08.015  0.318
2009 Silva JM, Ezhkova E, Silva J, Heart S, Castillo M, Campos Y, Castro V, Bonilla F, Cordon-Cardo C, Muthuswamy SK, Powers S, Fuchs E, Hannon GJ. Cyfip1 is a putative invasion suppressor in epithelial cancers. Cell. 137: 1047-61. PMID 19524508 DOI: 10.1016/J.Cell.2009.04.013  0.398
2009 Hsu DS, Acharya CR, Balakumaran BS, Riedel RF, Kim MK, Stevenson M, Tuchman S, Mukherjee S, Barry W, Dressman HK, Nevins JR, Powers S, Mu D, Potti A. Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 5312-7. PMID 19279207 DOI: 10.1073/Pnas.0900827106  0.34
2009 Starr TK, Allaei R, Silverstein KA, Staggs RA, Sarver AL, Bergemann TL, Gupta M, O'Sullivan MG, Matise I, Dupuy AJ, Collier LS, Powers S, Oberg AL, Asmann YW, Thibodeau SN, et al. A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science (New York, N.Y.). 323: 1747-50. PMID 19251594 DOI: 10.1126/Science.1163040  0.331
2009 Keng VW, Villanueva A, Chiang DY, Dupuy AJ, Ryan BJ, Matise I, Silverstein KA, Sarver A, Starr TK, Akagi K, Tessarollo L, Collier LS, Powers S, Lowe SW, Jenkins NA, et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nature Biotechnology. 27: 264-74. PMID 19234449 DOI: 10.1038/Nbt.1526  0.342
2009 Sawey ET, Cai C, Bakleh A, Liu Q, Lowe SW, Powers S. Abstract A39: An oncogenomics-basedin vivocDNA screen pinpoints coamplifiedCcnd1andFgf19as therapeutic targets for liver cancer Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-A39  0.385
2008 Hsu SD, Acharya CR, Riedel RF, Redman RC, Garman KS, Dressman HK, Ginsburg G, Powers S, Mu D, Potti A. Use of co-activation of lung cancer specific developmental pathway genes, TTF-1, NKX2-8, and PAX9, to predict prognosis and guide therapeutic strategies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 7511. PMID 27947211 DOI: 10.1200/Jco.2008.26.15_Suppl.7511  0.315
2008 Sangha N, Wu R, Kuick R, Powers S, Mu D, Fiander D, Yuen K, Katabuchi H, Tashiro H, Fearon ER, Cho KR. Neurofibromin 1 (NF1) defects are common in human ovarian serous carcinomas and co-occur with TP53 mutations. Neoplasia (New York, N.Y.). 10: 1362-72, following 1. PMID 19048115 DOI: 10.1593/Neo.08784  0.365
2008 Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, Zender P, Kubicka S, Luk JM, Schirmacher P, McCombie WR, Wigler M, Hicks J, Hannon GJ, Powers S, et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell. 135: 852-64. PMID 19012953 DOI: 10.1016/J.Cell.2008.09.061  0.407
2008 Miao J, Mu D, Ergel B, Singavarapu R, Duan Z, Powers S, Oliva E, Orsulic S. Hepsin colocalizes with desmosomes and induces progression of ovarian cancer in a mouse model. International Journal of Cancer. 123: 2041-7. PMID 18726901 DOI: 10.1002/Ijc.23726  0.378
2008 Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes & Development. 22: 1439-44. PMID 18519636 DOI: 10.1101/Gad.1672608  0.363
2008 Sinclair AM, Rogers N, Busse L, Archibeque I, Brown W, Kassner PD, Watson JE, Arnold GE, Nguyen KC, Powers S, Elliott S. Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells. British Journal of Cancer. 98: 1059-67. PMID 18349818 DOI: 10.1038/Sj.Bjc.6604220  0.301
2008 Degenhardt YY, Wooster R, McCombie RW, Lucito R, Powers S. High-content analysis of cancer genome DNA alterations. Current Opinion in Genetics & Development. 18: 68-72. PMID 18339543 DOI: 10.1016/J.Gde.2008.01.005  0.363
2008 Powers S, Mu D. Genetic similarities between organogenesis and tumorigenesis of the lung Cell Cycle. 7: 200-204. PMID 18256532 DOI: 10.4161/Cc.7.2.5284  0.326
2007 Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B, Gerald WL, Powers S, Mu D. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 104: 16663-8. PMID 17925434 DOI: 10.1073/Pnas.0708286104  0.33
2006 Pelham RJ, Rodgers L, Hall I, Lucito R, Nguyen KC, Navin N, Hicks J, Mu D, Powers S, Wigler M, Botstein D. Identification of alterations in DNA copy number in host stromal cells during tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 103: 19848-53. PMID 17167050 DOI: 10.1073/Pnas.0609635104  0.31
2006 Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 125: 1253-67. PMID 16814713 DOI: 10.1016/J.Cell.2006.05.030  0.393
2005 Zender L, Xue W, Cordón-Cardo C, Hannon GJ, Lucito R, Powers S, Flemming P, Spector MS, Lowe SW. Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors. Cold Spring Harbor Symposia On Quantitative Biology. 70: 251-61. PMID 16869761 DOI: 10.1101/Sqb.2005.70.059  0.325
2005 van der Horst EH, Degenhardt YY, Strelow A, Slavin A, Chinn L, Orf J, Rong M, Li S, See LH, Nguyen KQ, Hoey T, Wesche H, Powers S. Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proceedings of the National Academy of Sciences of the United States of America. 102: 15901-6. PMID 16247015 DOI: 10.1073/Pnas.0508014102  0.357
2004 Harrison M, Li J, Degenhardt Y, Hoey T, Powers S. Wip1-deficient mice are resistant to common cancer genes. Trends in Molecular Medicine. 10: 359-61. PMID 15310454 DOI: 10.1016/J.Molmed.2004.06.010  0.343
2004 Sin WC, Zhang Y, Zhong W, Adhikarakunnathu S, Powers S, Hoey T, An S, Yang J. G protein-coupled receptors GPR4 and TDAG8 are oncogenic and overexpressed in human cancers. Oncogene. 23: 6299-303. PMID 15221007 DOI: 10.1038/Sj.Onc.1207838  0.34
2003 Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, et al. Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Research. 13: 2291-305. PMID 12975311 DOI: 10.1101/Gr.1349003  0.314
2003 Mu D, Chen L, Zhang X, See LH, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KC, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, ... ... Powers S, et al. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell. 3: 297-302. PMID 12676587 DOI: 10.1016/S1535-6108(03)00054-0  0.34
2002 Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey T, Lowe SW, Powers S. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nature Genetics. 31: 133-4. PMID 12021784 DOI: 10.1038/Ng888  0.364
2001 Shields JM, Der CJ, Powers S. Identification of Ras-regulated genes by representational difference analysis Methods in Enzymology. 332: 221-232. PMID 11305099 DOI: 10.1016/S0076-6879(01)32205-X  0.334
2000 Lucito R, West J, Reiner A, Alexander J, Esposito D, Mishra B, Powers S, Norton L, Wigler M. Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Research. 10: 1726-36. PMID 11076858 DOI: 10.1101/Gr.138300  0.3
1995 Bhattacharya S, Chen L, Broach JR, Powers S. Ras membrane targeting is essential for glucose signaling but not for viability in yeast. Proceedings of the National Academy of Sciences of the United States of America. 92: 2984-8. PMID 7708760 DOI: 10.1073/Pnas.92.7.2984  0.33
1995 Jung V, Chen L, Hofmann SL, Wigler M, Powers S. Mutations in the SHR5 gene of Saccharomyces cerevisiae suppress Ras function and block membrane attachment and palmitoylation of Ras proteins. Molecular and Cellular Biology. 15: 1333-42. PMID 7532279 DOI: 10.1128/Mcb.15.3.1333  0.349
1994 Beranger F, Paterson H, Powers S, Gunzburg Jd, Hancock JF. The effector domain of Rab6, plus a highly hydrophobic C terminus, is required for Golgi apparatus localization. Molecular and Cellular Biology. 14: 744-758. PMID 8264642 DOI: 10.1128/Mcb.14.1.744  0.302
1994 Chen L, Powers S. A mutation in the effector region of Ras2 can be partially suppressed by alteration of a 'nonessential' region of Ras Gene. 147: 107-110. PMID 8088533 DOI: 10.1016/0378-1119(94)90047-7  0.345
1993 Lai CC, Boguski M, Broek D, Powers S. Influence of guanine nucleotides on complex formation between Ras and CDC25 proteins. Molecular and Cellular Biology. 13: 1345-52. PMID 8441380 DOI: 10.1128/Mcb.13.3.1345  0.344
1992 Ruggieri R, Bender A, Matsui Y, Powers S, Takai Y, Pringle JR, Matsumoto K. RSR1, a ras-like gene homologous to Krev-1 (smg21A/rap1A): Role in the development of cell polarity and interactions with the ras pathway in Saccharomyces cerevisiae Molecular and Cellular Biology. 12: 758-766. PMID 1732742 DOI: 10.1128/Mcb.12.2.758  0.368
1991 Powers S, Gonzales E, Christensen T, Cubert J, Broek D. Functional cloning of BUD5, a CDC25-related gene from S. cerevisiae that can suppress a dominant-negative RAS2 mutant. Cell. 65: 1225-31. PMID 1905982 DOI: 10.1016/0092-8674(91)90017-S  0.357
1991 He B, Chen P, Chen SY, Vancura KL, Michaelis S, Powers S. RAM2, an essential gene of yeast, and RAM1 encode the two polypeptide components of the farnesyltransferase that prenylates a-factor and Ras proteins. Proceedings of the National Academy of Sciences of the United States of America. 88: 11373-7. PMID 1763050 DOI: 10.1073/Pnas.88.24.11373  0.351
1991 Kim JH, Powers S. Overexpression of RPI1, a novel inhibitor of the yeast Ras-cyclic AMP pathway, down-regulates normal but not mutationally activated Ras function Molecular and Cellular Biology. 11: 3894-3904. PMID 1649384 DOI: 10.1128/Mcb.11.8.3894  0.365
1990 Field J, Vojtek A, Ballester R, Bolger G, Colicelli J, Ferguson K, Gerst J, Kataoka T, Michaeli T, Powers S, Riggs M, Rodgers L, Wieland I, Wheland B, Wigler M. Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd adenylyl cyclase-associated protein Cell. 61: 319-327. PMID 2184942 DOI: 10.1016/0092-8674(90)90812-S  0.344
1990 Goodman LE, Judd SR, Farnsworth CC, Powers S, Gelb MH, Glomset JA, Tamanoi F. Mutants of Saccharomyces cerevisiae defective in the farnesylation of Ras proteins. Proceedings of the National Academy of Sciences of the United States of America. 87: 9665-9. PMID 2124698 DOI: 10.1073/Pnas.87.24.9665  0.324
1989 Powers S, O'Neill K, Wigler M. Dominant yeast and mammalian RAS mutants that interfere with the CDC25-dependent activation of wild-type RAS in Saccharomyces cerevisiae. Molecular and Cellular Biology. 9: 390-5. PMID 2651897 DOI: 10.1128/Mcb.9.2.390  0.334
1988 Wigler M, Field J, Powers S, Broek D, Toda T, Cameron S, Nikawa J, Michaeli T, Colicelli J, Ferguson K. Studies of RAS function in the yeast Saccharomyces cerevisiae. Cold Spring Harbor Symposia On Quantitative Biology. 53: 649-55. PMID 3076094 DOI: 10.1101/Sqb.1988.053.01.074  0.304
1987 Broek D, Toda T, Michaeli T, Levin L, Birchmeier C, Zoller M, Powers S, Wigler M. The S. cerevisiae CDC25 gene product regulates the RAS/adenylate cyclase pathway. Cell. 48: 789-99. PMID 3545497 DOI: 10.1016/0092-8674(87)90076-6  0.382
1986 Powers S, Michaelis S, Broek D, Santa Anna S, Field J, Herskowitz I, Wigler M. RAM, a gene of yeast required for a functional modification of RAS proteins and for production of mating pheromone a-factor. Cell. 47: 413-22. PMID 3533274 DOI: 10.1016/0092-8674(86)90598-2  0.341
1985 Kataoka T, Powers S, Cameron S, Fasano O, Goldfarb M, Broach J, Wigler M. Functional homology of mammalian and yeast RAS genes. Cell. 40: 19-26. PMID 2981628 DOI: 10.1016/0092-8674(85)90304-6  0.35
1984 Powers S, Kataoka T, Fasano O, Goldfarb M, Strathern J, Broach J, Wigler M. Genes in S. cerevisiae encoding proteins with domains homologous to the mammalian ras proteins. Cell. 36: 607-12. PMID 6365329 DOI: 10.1016/0092-8674(84)90340-4  0.35
1984 Kataoka T, Powers S, McGill C, Fasano O, Strathern J, Broach J, Wigler M. Genetic analysis of yeast RAS1 and RAS2 genes. Cell. 37: 437-45. PMID 6327067 DOI: 10.1016/0092-8674(84)90374-X  0.353
Show low-probability matches.